PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFeladilimab
Feladilimab
Feladilimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target inducible T-cell costimulator.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
8 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Head and neck neoplasmsD006258222
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C80335
Multiple myelomaD009101C90.0111
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFeladilimab
INNfeladilimab
Description
Feladilimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target inducible T-cell costimulator.
Classification
Antibody
Drug classvasodilators (undefined group); monoclonal antibodies
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL4297969
ChEBI ID
PubChem CID
DrugBank
UNII IDOUP4QB2A3R (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
ICOS
ICOS
Organism
Homo sapiens
Gene name
ICOS
Gene synonyms
AILIM
NCBI Gene ID
Protein name
inducible T-cell costimulator
Protein synonyms
Activation-inducible lymphocyte immunomediatory molecule, CD278, inducible costimulator, inducible T-cell co-stimulator
Uniprot ID
Mouse ortholog
Icos (54167)
inducible T-cell costimulator (Q9WVS0)
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 125 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2 adverse events reported
View more details
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use